Lund, Sweden-based Yazen Health, the healthcare platform dedicated to combating obesity with modern weight loss medication and lifestyle changes, has announced the successful closing of an oversubscribed €19.5 million Series A funding round.

“With this funding, the company strengthens its position as a pioneer in obesity treatment and sets its sights on international expansion,” said the company.

The funding round was co-led by Evli Growth Partners of Finland and Helsana HealthInvest of Switzerland with participation from Almaz Capital and Yabeo of Germany.

Yazen was also supported in this funding round by existing Swedish investors Luminar Ventures and Aggregate Media.

“Obesity is one of the world’s most widespread health problems, and Yazen has developed a holistic model that can make a long-lasting impact,” said Yazen.

“By combining modern weight loss medication with a multidisciplinary team of doctors, coaches, dietitians, psychologists and physiotherapists, Yazen has helped over 20,000 patients in Sweden, showing an impressive 70% retention rate after one year …

“The investment will also enable further development of Yazen’s app and its holistic care service, designed to better support patients on their journey toward healthier lives.

“Yazen provides a complete care model where patients receive support from a dedicated team of doctors, YazenCoaches, psychologists, dietitians, and physiotherapists—delivering a comprehensive solution reflected in excellent customer reviews and engagement.

“It’s not just the medication that makes the difference; it’s the collaborative approach from the entire Yazen team that creates magic for patients.”

Yazen said that as a result of the funding round it welcomes Mikael Hed, founding partner at Evli Growth Partners and former CEO of Rovio, creators of Angry Birds, as the new chairman of its board.

‍“We are extremely proud of what we’ve achieved so far and the strong growth we’ve seen in Sweden,” said Fredrik Meurling, CEO and Founder of Yazen.

“This funding gives us the opportunity to continue our mission to defeat obesity on a global scale. With Mikael Hed as our new chairman and the support of our new investors, we are better positioned than ever to make a difference.”

Hed said: “Yazen’s comprehensive offering has quickly demonstrated an impressive track record. I look forward to leading the board’s work and, together with both existing and new investors, continuing Yazen’s international expansion.”